Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy

Richard L Wahl; Panithaya Chareonthaitawee; Bonnie Clarke; Alexander Drzezga; Liza Lindenberg; Arman Rahmim; James Thackeray; Gary A Ulaner; Wolfgang Weber; Katherine Zukotynski; John Sunderland

doi:10.2967/jnumed.120.253450

Back

Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy

Journal article

Open access

Peer reviewed

Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy

Richard L Wahl, Panithaya Chareonthaitawee, Bonnie Clarke, Alexander Drzezga, Liza Lindenberg, Arman Rahmim, James Thackeray, Gary A Ulaner, Wolfgang Weber, Katherine Zukotynski, …

The Journal of nuclear medicine (1978), Vol.62(1), pp.6-14

01/2021

DOI: 10.2967/jnumed.120.253450

PMCID: PMC9364879

PMID: 33334911

Files and links (1)

url

https://doi.org/10.2967/jnumed.120.253450View

Published (Version of record) Open Access

Abstract

The Society of Nuclear Medicine and Molecular Imaging created the Value Initiative in 2017 as a major component of its strategic plan to further demonstrate the value of molecular imaging and molecularly targeted radiopharmaceutical therapy to patients, physicians, payers, and funding agencies. The research and discovery domain, 1 of 5 under the Value Initiative, has a goal of advancing the research and development of diagnostic and therapeutic nuclear medicine. Research and discovery efforts and achievements are essential to ensure a bright future for NM and to translate science to practice. Given the remarkable progress in the field, leaders from the research and discovery domain and society councils identified 5 broad areas of opportunity with potential for substantive growth and clinical impact. This article discusses these 5 growth areas, identifying specific areas of particularly high importance for future study and development. As there was an understanding that goals should be both visionary yet achievable, this effort was called the Mars shot for nuclear medicine.

Humans

Molecular Imaging

Molecular Targeted Therapy

Neoplasms - diagnostic imaging

Neoplasms - drug therapy

Nuclear Medicine

Radiopharmaceuticals - pharmacokinetics

Radiopharmaceuticals - pharmacology

Radiopharmaceuticals - therapeutic use

Details

Title: Subtitle: Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
Creators: Richard L Wahl - Mallinckrodt
Panithaya Chareonthaitawee - Department of Cardiovascular Medicine, Mayo Clinic , Rochester, Minnesota.
Bonnie Clarke - Society of Nuclear Medicine and Molecular Imaging
Alexander Drzezga - German Center for Neurodegenerative Diseases
Liza Lindenberg - National Cancer Institute
Arman Rahmim - BC Cancer Research Centre
James Thackeray - Hannover Medical School
Gary A Ulaner - Memorial Sloan Kettering Cancer Center
Wolfgang Weber - Technical University of Munich
Katherine Zukotynski - McMaster University
John Sunderland - University of Iowa
Resource Type: Journal article
Publication Details: The Journal of nuclear medicine (1978), Vol.62(1), pp.6-14
DOI: 10.2967/jnumed.120.253450
PMID: 33334911
PMCID: PMC9364879
NLM abbreviation: J Nucl Med
ISSN: 1535-5667
eISSN: 1535-5667
Language: English
Date published: 01/2021
Academic Unit: Radiology; Physics and Astronomy; Radiation Oncology
Record Identifier: 9984313078502771

Metrics

13 Record Views

14 Times Cited - Web of Science